top of page
Search

Why 18 States Are Urging the FDA to Cut Red Tape on Mifepristone Access

ree

As attacks on reproductive rights escalate across the country, a powerful coalition of Democratic leaders is fighting back—with facts, data, and a clear demand for action.

A must-read article by Elisha Brown in State Newsroom outlines how 18 Democratic attorneys general and the Governor of Pennsylvania have formally petitioned the FDA to ease outdated and burdensome restrictions on mifepristone, a safe and widely used abortion medication.


Despite over 20 years of proven safety and more than 5 million uses, mifepristone remains entangled in red tape—especially paperwork that delays care, discourages providers, and complicates access via telemedicine. The petition calls out these restrictions for what they are: political barriers, not medical necessities.


This move comes just as conservative lawmakers ramp up legal threats and intimidation tactics to suppress access, including a $100,000 bounty bill in Texas targeting anyone involved in distributing abortion pills.


At a time when disinformation is being used to shape policy—like a recent HHS review prompted by a study from an anti-abortion think tank—this petition is a critical reminder that science, safety, and reproductive freedom must prevail.


💡 Take a moment to read Elisha Brown’s full report and stay informed about the legal and political battles shaping reproductive healthcare access in America.



 
 
 

Comments

bottom of page